These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23636109)

  • 21. Antihypertensive Medications and Eczematous Dermatitis in Older Adults.
    Ye M; Chan LN; Douglas I; Margolis DJ; Langan SM; Abuabara K
    JAMA Dermatol; 2024 May; ():. PubMed ID: 38776099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telaprevir-related dermatitis.
    Roujeau JC; Mockenhaupt M; Tahan SR; Henshaw J; Martin EC; Harding M; van Baelen B; Bengtsson L; Singhal P; Kauffman RS; Stern RS
    JAMA Dermatol; 2013 Feb; 149(2):152-8. PubMed ID: 23560295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical and histopathologic spectrum of "dermal hypersensitivity reactions," a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a "dermal hypersensitivity reaction pattern".
    Fung MA
    J Am Acad Dermatol; 2002 Dec; 47(6):898-907. PubMed ID: 12451376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diltiazem-induced drug eruption sparing seborrheic keratoses.
    Heymann WR
    Cutis; 2000 Aug; 66(2):129-30. PubMed ID: 10955194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium channel blockers intake and psoriasis: a case-control study.
    Cohen AD; Kagen M; Friger M; Halevy S
    Acta Derm Venereol; 2001; 81(5):347-9. PubMed ID: 11800142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction.
    Bircher AJ; Flückiger R; Buchner SA
    Br J Dermatol; 1990 Oct; 123(4):507-14. PubMed ID: 2151304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical characterization of cutaneous drug eruptions by STI571.
    Park HJ; Kim HS; Kim HJ; Lee JY; Cho BK; Lee AW; Yoon DY; Cho DH
    J Dermatol Sci; 2005 Apr; 38(1):9-15. PubMed ID: 15795119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The spectrum of cutaneous reactions associated with diltiazem: three cases and a review of the literature.
    Knowles S; Gupta AK; Shear NH
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):201-6. PubMed ID: 9486675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eczematous drug eruption after ustekinumab treatment.
    Pernet C; Guillot B; Bessis D
    Arch Dermatol; 2012 Aug; 148(8):959-60. PubMed ID: 22911203
    [No Abstract]   [Full Text] [Related]  

  • 30. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C.
    Tavakoli-Tabasi S; Bagree A
    J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maculopapular type drug eruption caused by pregabalin: A case and literature review.
    Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Allergol Int; 2016 Jul; 65(3):351-2. PubMed ID: 26976337
    [No Abstract]   [Full Text] [Related]  

  • 32. Asteatotic eczema ('eczema craquelé') with histopathological interface dermatitis: a new cutaneous reaction following pemetrexed.
    Frouin E; Sebille G; Freudenberger S; Menecier B; Quoix E; Cribier B; Lipsker D
    Br J Dermatol; 2012 Jun; 166(6):1359-60. PubMed ID: 22182200
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous reactions induced by calcium channel blocker: high frequency of psoriasiform eruptions.
    Kitamura K; Kanasashi M; Suga C; Saito S; Yoshida S; Ikezawa Z
    J Dermatol; 1993 May; 20(5):279-86. PubMed ID: 8340532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic eczematiform eruption in the elderly].
    Morin C; Joly P; Courville P; Young P; Richard C; Balguerie X; Lauret P
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):19-22. PubMed ID: 11937924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spongiotic (eczematous-type) dermatitis after inhaled budesonide.
    Holmes P; Cowen P
    Aust N Z J Med; 1992 Oct; 22(5):511. PubMed ID: 1445051
    [No Abstract]   [Full Text] [Related]  

  • 36. Eczematous eruption in patients with psoriasis during risankizumab treatment.
    Kromer C; Schön MP; Mössner R
    Eur J Dermatol; 2020 Oct; 30(5):599-601. PubMed ID: 33185530
    [No Abstract]   [Full Text] [Related]  

  • 37. Reticulated phototoxic eruption in a patient on long-term diltiazem therapy.
    Hanson M; Petronic-Rosic V
    J Drugs Dermatol; 2008 Aug; 7(8):792-3. PubMed ID: 18720699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors of eczema-like eruptions among patients without cutaneous psoriasis receiving infliximab: a cohort study of 92 patients.
    Esmailzadeh A; Yousefi P; Farhi D; Bachmeyer C; Cosnes J; Berenbaum F; Duriez P; Aractingi S; Khosrotehrani K
    Dermatology; 2009; 219(3):263-7. PubMed ID: 19684381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin reactions to carbamazepine.
    Roberts DL; Marks R
    Arch Dermatol; 1981 May; 117(5):273-5. PubMed ID: 6452860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.